Is Quantum Computing a Buy Right Now? Excitement about the company's commercial applicability is growing, but the risks remain significant.
The Best Dividend Stocks to Buy and Hold Forever in 2026 It could be an excellent time to add some top-quality REITs to your portfolio.
Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check Dutch Bros reported a 30.8% revenue surge in Q1, beating estimates. Despite raised guidance and aggressive expansion, shares fell on margin and growth concerns.
Why Are Some Investors Excited About Meta Platforms After Its Q1 Earnings? Meta gave investors something important in its latest earnings: Early proof that its AI investments are starting to pay off.
3 Transportation Stocks Built for the Long Haul Transportation stocks are decidedly old-line industrial fare, but that status could work in favor of long-term investors.
Why Oklo Stock Surged 46% in April Is the nuclear energy stock set for another big jump after May 12? Find out.
Wells Fargo’s Comeback Is Real—But Not Risk-Free Wells Fargo stock is gaining renewed attention as loan growth accelerates, shareholder returns rise, and analysts weigh lingering risks and upside potential.
Pinterest's Earnings Surge: A Short-Lived Spike or a Start of a Recovery? The Pinterest stock rally can continue, but it's too early to call this a full recovery.
Arbor Realty Trust (NYSE:ABR) Surprises With Q1 CY2026 Sales Real estate investment trust Arbor Realty Trust (
NYSE:ABR ) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 12.5% yea...
Entravision Shares Surge 80% This Week: What Investors Need To Know Entravision Communications (
NYSE: EVC ) shares are edging higher Friday as investors lean into earnings-driven reset after Q1 ad-tech surge.
Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy Capricor sued Nippon Shinyaku over Deramiocel distribution terms, citing pricing issues and patient access risks.
Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know Moderna Inc (
NASDAQ: MRNA ) shares are trading higher Friday morning as traders react to peer reviewed Phase 3 flu-vaccine data.
